Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors

Annals of the New York Academy of Sciences

Volumn 890, Issue , 1999, Pages 438-449

  Kingston, Ann E ^a   O'Neill, M J ^a   Bond, A ^a   Bruno, V ^b   Battaglia, G ^b   Nicoletti, F ^b   Harris, J R ^a   Clark, B P ^a   Monn, J A ^a   Lodge, D ^a   Schoepp, D D ^a  

^a ELI LILLY AND COMPANY   (United States)

^b IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 AMINO 2 THIABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; EGLUMETAD; GLUTAMATE RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; NEUROPROTECTIVE AGENT; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN ISCHEMIA; CONFERENCE PAPER; CONTROLLED STUDY; FETUS; GERBIL; HIPPOCAMPUS; MALE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT;

ANIMALIA; GERBILLINAE;

EID: 0033403170     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08022.x     Document Type: Conference Paper

References (31)

1. 1. Danysz, W., C.G. Parsons, I. Bresink & G. Quack. 1995. Glutamate in CNS disorders. Drug News Perspect. 8: 458-535.
2. 2. Buisson, A. & D.W. Choi. 1995. The inhibitory mGluR agonist, S-4-carboxy-3-hydroxyphenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death. Neuropharmacology 34: 1081-1087.
3. 3. Bruno, V., A. Copani, T. Knopfel, R. Kuhn, G. Casabona, P. Dell'Albani, D.F. Condorelli & F. Nicoletti. 1995. Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells. Neuropharmacology 34: 1089-1098.
4. 4. Pizzi, M., P. Galli, O. Consolandi, V. Arrighi, M. Merno & P.F. Spano. 1996. Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic calcium concentration and excitotoxicity in cultured cerebellar granule cells: pivotal role of protein kinase. Cell. Mol. Pharmacol. 49: 586-594.
5. 5. McDonald, J.W. & D.D. Schoepp. 1992. The metabotropic excitatory amino acid receptor agonist 1S,3R-ACPD selectively potentiates N-methyl-D-aspartate induced brain injury. Eur. J. Pharmacol. 215: 353-354.
6. 6. Sacaan, A.I. & D.D. Schoepp. 1992. Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage. Neurosci. Lett. 139: 77-82.
7. 7. Opitz, T., P. Richter & K.G. Reymann. 1994. The metabotropic glutamate receptor antagonist (+)-α-methyl-4-carboxyphenylglycine protects hippocampal CA1 neurons of the rat from in vitro hypoxia/hypoglycaemia. Neuropharmacology 33: 715-717.
8. 8. Riedel, G., T. Opitz & K.G. Reymann. 1996. Blockade of metabotropic glutamate receptors protects hippocampal neurons from hypoxia-induced cell death in rat in vivo. Prog. Neuro-Psychopharmacol Biol. Psychiat. 20: 1253-1263.
9. 9. Cozzi, A., G. Lombardi, P. Leonardi, S. Attuci, F. Peruginelli, R. Pellicciari & F. Moroni. 1997. AIDA, a group I metabotropic glutamate receptor antagonist reduces the ischemia-induced neuronal loss [abstract]. Soc. Neurosci. Abstr. 23: 788.2.
10. 10. Bruno, V., G. Battaglia, A. Kingston, M.J. O'Neill, M.V. Catania, R. Di Grezia & F. Nicoletti. 1999. Neuroprotective activity of the potent and selective mGlula metabotropic glutamate receptor antagonist, (+)-2-methyl-4-carboxyphenylglycine (LY367385): comparison with LY367366, an antagonist of mGlula and mGlu5 receptors. Neuropharmacology 38: 199-207.
11. 11. Bruno, V., A. Copani, G. Battaglia, R. Raffaele, H. Shinozaki & F. Nicoletti. 1994. Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal cell death. Eur. J. Pharmacol. 256: 109-112.
12. 12. Buisson, A., S.P. Yu & D.W. Choi. 1996. DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons. Eur. J. Neurosci. 8: 138-143.
13. 13. Battaglia, G., V. Bruno, R.T. Ngomba, R. Di Grezia, A. Copani & F. Nicoletti. 1998. Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death. Eur. J. Pharmacol. 356: 271-274.
14. 14. Copani, A., V. Bruno, G. Battaglia, G. Leanza, R. Pellitteri, A. Russo, S. Stanzani & F. Nicoletti. 1995. Activation of metabotropic glutamate receptors protects neurons against apoptosis induced by beta-amyloid peptide. Mol. Pharmacol. 47: 890-897.
15. 15. Maiese, K., R. Greenberg, L. Boccone & M. Swiriduk. 1994. Activation of metabotropic glutamate receptors is neuroprotective during nitric oxide toxicity in primary hippocampal neurons of rats. Neurosci. Lett. 194: 173-176.
16. 16. Buisson, A., S.P. Yu & D.W. Choi. 1994. Effect of metabotropic glutamate receptor agonists on excitotoxic and apoptotic cell death in murine cortical cell culture [abstract]. Soc. Neurosci. Abstr. 20: 198.5.
17. 17. Kingston, A.E., M.J. O'Neill, A. Lam, K.R. Bales, J.A. Monn & D.D. Schoepp. 1999. Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795. Eur. J. Pharmacol. 377: 155-165.
18. 18. Chiamulera, C., P. Albertini, E. Valerio & A. Reggiani. 1992. Activation of metabotropic receptors has a neuroprotective effect in a rodent model of focal ischaemia. Eur. J. Pharmacol. 216: 335-336.
19. 19. Shinozaki, H., M. Ishida, M. Miyamoto & S. Kwak. 1994. Sedative and neuroprotective actions of potent and selective agonists for metabotropic glutamate receptors. In Excitatory Amino Acids: Approaches to Clinical Uses. The Ninth Rinshoken International Conference. Nov. 28-30, Tokyo, Japan. Abst. 25.
20. 20. Bond, A., M.J. O'Neill, C.A. Hicks, J.A. Monn & D. Lodge. 1998. Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. NeuroReport 9: 1191-1193.
21. 21. Bond, A., N. Ragumoorthy, J.A. Monn, C.A. Hicks, M.A. Ward, D. Lodge & M.J. O'Neill. 1999. LY379268, a potent and selective group II metabotropic glutamate receptor agonist is neuroprotective in gerbil global, but not focal, cerebral ischemia. Neurosci. Lett. 273: 191-194.
22. 22. Clark, B.P., S.R. Baker, J. Goldsworthy, J.R. Harris & A.E. Kingston. 1997. (+)-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGlul receptors. Biorg. Med. Chem. Lett. 7: 2777-2780.
23. 3H]-glutamate binding sites in the rat brain. J. Neurochem. 63: 938-945.
24. 24. Schoepp, D.D., B.G. Johnson, R.A. Wright, C.R. Salhoff, N.G. Mayne, S. Wu, S.L. Cockerham, J.P. Burnett, R. Belagaje, D. Bleakman & J.A. Monn. 1997. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology 36: 1-11.
25. 25. Schoepp, D.D., D. Lodge, D. Bleakman, J.D. Leander, J.P. Tizzano, R.A. Wright, A.J. Palmer, C.R. Salhoff & P.L. Ornstein. 1995. In vitro and in vivo antagonism of AMPA receptor activation by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl] decahydroisoquinaline-3-carboxylic acid. Neuropharmacology 34: 1159-1168.
26. 26. Chen, C.-K., F.S. Silverstein, S.K. Fisher, D. Statman & M.V. Johnston. 1988. Perinatal hypoxic-ischemic brain injury enhances quisqualic acid stimulated phosphoinositide turnover. J. Neurochem. 51: 353-359.
27. 27. Seren, M.S., C. Aldinio, R. Zanoni, A. Leon & F. Nicoletti. 1989. Stimulation of inositol phospholipid hydrolysis by excitatory amino acids is enhanced in brain slices from vulnerable regions after transient global ischaemia. J. Neurochem. 53: 1700-1705.
28. 28. Schoepp, D.D. & P.J. Conn. 1993. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol. Sci. 14: 13-20.
29. 29. Chavis, P., J.M. Nooney, J. Bockaert, L. Fagni, A. Feltz & J.L. Bossu. 1995. Facilitatory coupling between a glutamate metabotropic receptor and dihydropyridine-sensitive calcium channels in cultured cerebellar granule cells. J. Neurosci. 15: 135-143.
30. 30. Battaglia, G., J.A. Monn & D.D. Schoepp. 1997. In vivo inhibition of veratridine evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats. Neurosci. Lett. 229: 161-164.
31. 31. Bruno, V., G. Battaglia, G. Casabona, A. Copani, F. Cacgli & F. Nicoletti. 1998. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor beta. J. Neurosci. 18: 9594-9600.